Report from Wuhan Huoshenshan Hospital to fight against Covid-19
Singleron CEO and founder Dr. Nan Fang to present at WCLC conference on Lung Cancer study
Singleron technologies secured a pre-series A financing worth more than $10M
Copyright © 2022 Singleron Biotechnologies